Astellas celebrates significant award wins for sustainability efforts
In March, Astellas picked up the Commitment to Sustainability Award at the well-known IDA supported Invest in Ireland Awards. These awards reward excellence in the inward foreign direct investment sector in the Republic of Ireland. Astellas won the award in recognition of the environmental and sustainability stewardship the judges felt was at the heart of Astellas' operations. The awards acknowledged Astellas' significant investment in renewable energy, waste reduction and greener manufacturing practices which contributed to its win on the night.
Astellas also enjoyed huge success at the Green Awards in February. With 140 companies submitting 280 entries to compete across 29 categories, Astellas received four awards on the night. These included Green Large Organisation of the Year, Sustainability Team of the Year, the Green Lifesciences Award and the Sustainable Energy Achievement Award.
Speaking about the award wins, Louis Collins, Executive Director and Site Lead, Astellas Co. Ltd. said:
'Our strong culture of sustainability has been embedded in everything we do since the early 2000s. We're hugely aware of the role our work plays in patients' lives and the communities we operate in. With that in mind, our sustainability approach incorporates all of our key stakeholders, from patients and our community to our employees, with the understanding that our continued growth and success needs to be achieved as sustainably as possible.
Through a range of initiatives and ongoing investment in renewable technologies, Astellas Kerry now meets 74% of its energy needs from renewable sources. Since 2005, we have achieved a 98% reduction in CO₂ emissions and a 70% reduction in the generation of non-hazardous waste.
These award wins are a clear demonstration that our operations reflect our commitments to our stakeholders.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RTÉ News
02-07-2025
- RTÉ News
'The canary in the mine' - US tariff threat impacts Offaly firm
The threat of US tariffs is having an impact on Irish businesses, and the uncertainty is leaving many in limbo. At a trade forum in Dublin today, Tánaiste Simon Harris will say US tariffs of 10% on exports from Ireland will be the "new normal" but that efforts are continuing to agree zero for zero taxes in some key areas. The meeting takes place a week before the scheduled lifting of a pause on higher tariffs by US President Donald Trump. The forum will also receive an economic assessment of the impact of tariffs from Minister for Finance Paschal Donohoe. At Elis Cleanroom in Co Offaly, they describe themselves as "the canary in the mine". It is, according to the sales manager Bernard Flynn, "a good barometer of what is happening in the industry". The company, which has a base in Birr, Co Offaly, and in Glanmire, Co Cork, provides specialist laundry services, both sterile and non-sterile, to companies which work in controlled environments, including the medical device and pharmaceutical industries. "Our service is a very vital service to the pharma and medical device sector so we're right there at the core," Mr Flynn said. "If they sneeze, we get a cold, essentially. "So we need to, or we would like to know, what's going to happen and we would like some stability and some certainty". In the cleanroom section of the business, Elis employs 100 people, while overall, the company employs around 1,300 people in Ireland. "For last ten years we've had double digit growth," said Mr Flynn. He added that to continue growing, more customers are needed. "Year on year, it's been fantastic but the big news now is there has been no news and by that, I mean we've had no announcements of new builds in the last ten months. "We currently have two brownfield sites being built - Astellas in Tralee, Co Kerry, and Dexcom in Athenry, Co Galway. Outside of that, there have been absolutely no announcements. "At the moment, things are holding steady but we would like to see a stimulus, something to help us and to give us some clarity, because we're part of a bigger organisation." Without growth, Mr Flynn said, investment is uncertain. "Elis is a worldwide organisation, and we have to report back. We get investment based on the future and the growth of the company. "We've had great investment, year on year on year, but we need to be able to show that there's something coming in the future, in order to continue that investment into our two plants here. "There's nothing as bad as not knowing." He added that the industry hopes Minister for Enterprise Peter Burke will work with them to work out the tariffs, whatever they may be. "We need to work to help reduce the costs for companies and be part of the conversation, so that we can continue to keep employment going," he said.
RTÉ News
02-07-2025
- RTÉ News
Industries want to be part of the conversation on US tariffs
The threat of tariffs is having an impact on Irish businesses, and the uncertainty is leaving many in limbo. At Elis Cleanroom in Co Offaly, they describe themselves as "the canary in the mine". It is, according to the sales manager Bernard Flynn, "a good barometer of what is happening in the industry". The company which has a base in Birr, Co Offaly and in Glanmire, Co Cork, provides specialist laundry services both sterile and non-sterile, to companies which work in controlled environments, including the medical device and pharmaceutical industries. "Our service is a very vital service to the pharma and medical device sector so we're right there at the core," Mr Flynn said. "If they sneeze, we get a cold, essentially. "So we need to, or we would like to know, what's going to happen and we would like some stability and some certainty". In the cleanroom section of the business, Elis employ 100 people, while overall, the company employs around 1,300 people in Ireland. "For last ten years we've had double digit growth," said Mr Flynn. He added that to continue growing, more customers are needed. "Year on year, it's been fantastic but the big news now is there has been no news and by that, I mean we've had no announcements of new builds in the last ten months. "We currently have two brownfield sites being built - Astellas in Tralee, Co Kerry, and Dexcom in Athenry, Co Galway. Outside of that, there have been absolutely no announcements. "At the moment, things are holding steady but we would like to see a stimulus, something to help us and to give us some clarity, because we're part of a bigger organisation". Without growth, Mr Flynn said, investment is uncertain. "Elis is a worldwide organisation, and we have to report back. We get investment based on the future and the growth of the company. "We've had great investment, year on year on year, but we need to be able to show that there's something coming in the future, in order to continue that investment into our two plants here. "There's nothing as bad as not knowing". He added that the industry hopes Minister for Enterprise Peter Burke will work with them to work out the tariffs, whatever they may be. "We need to work to help reduce the costs for companies and be part of the conversation, so that we can continue to keep employment going," he said.
Irish Post
29-06-2025
- Irish Post
Japanese pharmaceutical company Astellas to invest €129m in its Irish operations
JAPANESE pharmaceutical company Astellas has revealed it will invest €129m in its Irish operations over the next three years. The multi-site investments, focusing on development, sustainability and Research Development & Innovation (RD&I), aim to enhance Astellas' operations across the country. Lisa Murphy, General Manager of Astellas Pharma, said the investment is a testament to 'the great relationship that Astellas has with the local community and local officials'. Proposals One of Japan's largest life sciences companies and a leading developer and manufacturer of pharmaceutical products, Astellas has a heritage in Ireland spanning more than 35 years. The company currently employs in excess of 650 people across two facilities in Killorglin, Co. Kerry and Mulhuddart, Co. Dublin. The proposed investment, supported by IDA Ireland, reinforce Astellas' long-term commitment to Ireland as a strategic hub for its global manufacturing, research and development activities. The investment will see Astellas Killorglin implement several initiatives to significantly reduce energy consumption and CO₂ emissions. In Dublin, the company is embarking on a project to improve environmental sustainability through the installation of solar panels and heat pumps across multiple facilities. Meanwhile, a new Tralee facility due to be fully operational in 2028 will create 120 new jobs and will accelerate the expansion of Astellas' in-house production capabilities. Speaking about the proposals, Ms Murphy said: "We're delighted to see great progress across the various projects ongoing across the Astellas' operational footprint here in Ireland. "The continued investment by Astellas in Ireland will expand our capacity and capabilities for aseptic drug products, reinforce stable production for global supply, and accelerate the development and commercialisation of innovative antibody drugs and other new products." 'Key location' Peter Burke, Minister for Enterprise, Tourism and Employment, recently met with members of the Astellas senior leadership team in Tokyo. Speaking from the city, he said: "This commitment by Astellas highlights Ireland's role in the global life sciences sector. "Our ongoing investment in education, infrastructure and innovation continues to create the optimum environment for companies to thrive. "Astellas' decision to grow its footprint in both Kerry and Dublin demonstrates the strength of Ireland's offering and our commitment to supporting enterprise development across all regions." Michael Lohan, CEO of IDA Ireland, said the news showed that Ireland continues to attract strategic investments from world-leading companies. "Astellas' long-standing presence here and its ongoing commitment to both Dublin and Kerry is a testament to the strength of our partnership and the value Ireland offers as a key location for innovation and growth," he added. See More: Astellas, Dublin, Kerry, Killorglin, Mulhuddart
